One of the most important intentions of SBI has been to build a strong infrastructure and to attract research collaborators.
SBI comprises academic, industrial, and public partners. These partners work in collaboration to accomplish a comprehensive multi-disciplinary research infrastructure.
As with any university research, students and their advisors are in active discussion, and many have co-supervision with scientists from the public sector and/or private industry. The SBI researchers form the academic and innovative environment from which new research ideas originate and into which new methods and techniques are introduced to stimulate growth.
In collaboration with industrial partners from the biomedical and biotechnical industry, and with public partners in health care and education, new knowledge will be used to develop biomarkers to detect and follow disease processes, as well as to develop new programmes for prevention, intervention and learning.
- Atlas Antibodies
- AstraZeneca AB
- GE Healthcare
- Karolinska Institutet Innovations AB (KIAB)
- Mediso Medical Imaging Systems
- Mentis Cura
- Tedroff NeuroCare AB